专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20100169257A1 TRANSPARENT PARALLELISM AMONG LINEAR SOLVERS 有权
标题翻译：线性解决方案中的透明并行列表
公开(公告)号：US20100169257A1
公开(公告)日：2010-07-01
申请号：US12345060
申请日：2008-12-29
申请人： Min Wei , Alexander Sasha Stojanovic , David Lao
发明人： Min Wei , Alexander Sasha Stojanovic , David Lao
IPC分类号： G06F17/11 , G06N5/02
CPC分类号： G06F17/11
摘要： A model, which defines a mathematical problem, and multiple directives may be received. Each of the multiple directives may be mapped to a respective linear solver instance. The linear solver instances may be launched to execute in parallel. Each of the linear solver instances may use either a primal or a dual algorithm and may further use double arithmetic, exact arithmetic, or hybrid arithmetic, as specified by corresponding ones of the multiple directives. A linear solver instance that uses hybrid arithmetic may start by using double arithmetic and may use exact arithmetic after experiencing a numerical difficulty. After the numerical difficulty is resolved, the linear solver instance that uses hybrid arithmetic may restart and continue to solve the mathematical problem using double arithmetic. After one of the linear solver instances finds an optimal solution, others of the linear solver instances may be stopped and a report may be provided.
摘要翻译：可以接收定义数学问题的模型和多个指令。多个伪指令中的每一个可以被映射到相应的线性求解器实例。可以启动线性求解器实例并行执行。每个线性求解器实例可以使用原始算法或双重算法，并且可以进一步使用由多个指令中的相应指令指定的双运算，精确算术或混合运算。使用混合算术的线性求解器实例可以通过使用双运算来开始，并且可能在遇到数值难题之后使用精确算术。数值难题解决后，使用混合算法的线性求解器实例可以重新启动，并继续使用双重算法解决数学问题。在线性求解器实例中的一个找到最优解之后，可以停止线性求解器实例中的其他实例，并且可以提供报告。

2. 发明申请

US20100161289A1 FRAMEWORK FOR INTEROPERABILITY OF SOLVERS 有权
标题翻译：解决方案互操作性框架
公开(公告)号：US20100161289A1
公开(公告)日：2010-06-24
申请号：US12338159
申请日：2008-12-18
申请人： Alexander Sasha Stojanovic , Min Wei
发明人： Alexander Sasha Stojanovic , Min Wei
IPC分类号： G06F17/12 , G06F17/11 , G06F9/44
CPC分类号： G06F17/10 , G06F8/51
摘要： A framework may be provided for facilitating adoption of mathematical and logical solvers. A model, representing a problem, may be defined. The model may be defined: via a series of statements in a type safe common-language-specification compliant modeling language; via an intermediate format; or via a series of calls to a standardized application program interface. The framework may translate the defined model to an intermediate format, which many solvers may understand. The framework may provide a number of solver-related services including, but not limited to, services for creating a model, analyzing a model, selecting a well-suited solver based on analysis of a model, decomposing a model into multiple sub-models and providing the multiple sub-models to multiple solvers as multiple parallel threads, data binding, simulation, and post optimality analysis.
摘要翻译：可以提供框架以便于采用数学和逻辑解算器。可以定义代表问题的模型。该模型可以被定义：通过一系列语言的类型安全的通用语言规范兼容的建模语言; 通过中间格式; 或通过一系列对标准化应用程序接口的调用。框架可以将定义的模型转换为中间格式，许多解算器可以理解。该框架可以提供许多解算器相关服务，包括但不限于用于创建模型的服务，分析模型，基于模型分析选择合适的求解器，将模型分解为多个子模型，以及将多个子模型提供给多个解算器作为多个并行线程，数据绑定，模拟和后期最优分析。

3. 发明授权

US08266601B2 Framework for interoperability of solvers 有权
标题翻译：求解器互操作框架
公开(公告)号：US08266601B2
公开(公告)日：2012-09-11
申请号：US12338159
申请日：2008-12-18
申请人： Alexander Sasha Stojanovic , Min Wei
发明人： Alexander Sasha Stojanovic , Min Wei
IPC分类号： G06F9/45
CPC分类号： G06F17/10 , G06F8/51
摘要： A framework may be provided for facilitating adoption of mathematical and logical solvers. A model, representing a problem, may be defined. The model may be defined: via a series of statements in a type safe common-language-specification compliant modeling language; via an intermediate format; or via a series of calls to a standardized application program interface. The framework may translate the defined model to an intermediate format, which many solvers may understand. The framework may provide a number of solver-related services including, but not limited to, services for creating a model, analyzing a model, selecting a well-suited solver based on analysis of a model, decomposing a model into multiple sub-models and providing the multiple sub-models to multiple solvers as multiple parallel threads, data binding, simulation, and post optimality analysis.
摘要翻译：可以提供框架以便于采用数学和逻辑解算器。可以定义代表问题的模型。该模型可以被定义：通过一系列语言的类型安全的通用语言规范兼容的建模语言; 通过中间格式; 或通过一系列对标准化应用程序接口的调用。框架可以将定义的模型转换为中间格式，许多解算器可以理解。该框架可以提供许多解算器相关服务，包括但不限于用于创建模型的服务，分析模型，基于模型分析选择合适的求解器，将模型分解为多个子模型，以及将多个子模型提供给多个解算器作为多个并行线程，数据绑定，模拟和后期最优分析。

4. 发明授权

US08150789B2 Transparent parallelism among linear solvers 有权
标题翻译：线性求解器之间的透明平行度
公开(公告)号：US08150789B2
公开(公告)日：2012-04-03
申请号：US12345060
申请日：2008-12-29
申请人： Min Wei , Alexander Sasha Stojanovic , David Lao
发明人： Min Wei , Alexander Sasha Stojanovic , David Lao
IPC分类号： G06F17/00 , G06N5/02
CPC分类号： G06F17/11
摘要： A model, which defines a mathematical problem, and multiple directives may be received. Each of the multiple directives may be mapped to a respective linear solver instance. The linear solver instances may be launched to execute in parallel. Each of the linear solver instances may use either a primal or a dual algorithm and may further use double arithmetic, exact arithmetic, or hybrid arithmetic, as specified by corresponding ones of the multiple directives. A linear solver instance that uses hybrid arithmetic may start by using double arithmetic and may use exact arithmetic after experiencing a numerical difficulty. After the numerical difficulty is resolved, the linear solver instance that uses hybrid arithmetic may restart and continue to solve the mathematical problem using double arithmetic. After one of the linear solver instances finds an optimal solution, others of the linear solver instances may be stopped and a report may be provided.
摘要翻译：可以接收定义数学问题的模型和多个指令。多个伪指令中的每一个可以被映射到相应的线性求解器实例。可以启动线性求解器实例并行执行。每个线性求解器实例可以使用原始算法或双重算法，并且可以进一步使用由多个指令中的相应指令指定的双运算，精确算术或混合运算。使用混合算术的线性求解器实例可以通过使用双运算来开始，并且可能在遇到数值难题之后使用精确算术。数值难题解决后，使用混合算法的线性求解器实例可以重新启动，并继续使用双重算法解决数学问题。在线性求解器实例中的一个找到最优解之后，可以停止线性求解器实例中的其他实例，并且可以提供报告。

5. 发明授权

US11278666B2 Medication infusion device 有权
公开(公告)号：US11278666B2
公开(公告)日：2022-03-22
申请号：US16686186
申请日：2019-11-17
申请人： Min Wei
发明人： Min Wei
IPC分类号： A61M5/00 , A61M5/142 , A61M5/145 , A61M5/168 , A61M5/158
摘要： A medication infusion device includes a medication container containing liquid medication; an infusion needle; and a reciprocating pump having a pump chamber. The liquid medication is withdrawn from the medication container into the pump chamber during suction operation of the reciprocating pump, and the liquid medication is dispensed out of the pump chamber through the infusion needle during dispensing operation of the reciprocating pump. There are also mechanisms preventing liquid from flowing through the infusion needle during suction operation of the reciprocating pump and preventing liquid from flowing back into the medication container during dispensing operation of the reciprocating pump. The medication infusion device may further include a microcontroller to control medication infusion volume and rate.

6. 发明授权

US10692590B2 Method for conducting adaptive clinical trial with drug delivery device 有权
公开(公告)号：US10692590B2
公开(公告)日：2020-06-23
申请号：US15471035
申请日：2017-03-28
申请人： Min Wei
发明人： Min Wei
IPC分类号： G16H10/20 , G06F19/00
摘要： The method set out herein involves conducting adaptive clinical trial to develop parenteral therapeutic product with variable dose drug delivery devices. The method comprises using a variable dose drug delivery device to respond modifications during the adaptive clinical trial, wherein the variable dose drug delivery device is able to deliver more than one dose level and is for delivering fluid formulation. Other methods set out herein involve using a variable dose drug delivery device equipped with radio frequency identification (RFID) or near field communication (NFC) technology to improve patient adherence to drug administration in the adaptive clinical trial.

7. 发明申请

US20200179612A1 Drug Delivery Device 审中-公开
公开(公告)号：US20200179612A1
公开(公告)日：2020-06-11
申请号：US16699002
申请日：2019-11-28
申请人： Min Wei
发明人： Min Wei
IPC分类号： A61M5/32 , A61M5/315
摘要： A drug delivery device comprises a medication container containing medication for delivery and a detachable unit having an electronic circuit with a microprocessor. The electronic circuit is open and non-operational when the detachable component is assembled on the drug delivery device; and the electronic circuit is closed and operational when the detachable component is detached from the drug delivery device. The detachment of the detachable unit is an essential step to operate the drug delivery device. The detachable unit can be an activation protection cap or a needle shield remover for an autoinjector device. Alternatively, the detachable unit can be a needle shield remover for a pre-filled syringe.

8. 发明授权

US10300203B2 Priming mechanism for automatic injection device 有权
公开(公告)号：US10300203B2
公开(公告)日：2019-05-28
申请号：US15665519
申请日：2017-08-01
申请人： Min Wei
发明人： Min Wei
IPC分类号： A61M5/315 , A61M5/31 , A61M5/20
摘要： A priming mechanism for operating an automatic injection apparatus to ensure medication contents are properly delivered prior to a needled syringe of the apparatus being injected. The priming mechanism includes a push rod to move plunger(s) within the syringe; a releasable support including bendable supporting arms, which limiting motion of the syringe relative to an upper housing body before and during priming; and a recess element inside the lower housing body to release said bendable arm to allow motion of the syringe relative to the upper housing body in distal direction after priming. In one form, the priming mechanism is used for removing air bubble before injection to ensure delivering correct dose. In another form, the priming mechanism is used to mix different contents in a dual chamber syringe before injection.

9. 发明申请

US20180250474A1 Syringe Type Medication Delivery Device 审中-公开
公开(公告)号：US20180250474A1
公开(公告)日：2018-09-06
申请号：US15910156
申请日：2018-03-02
申请人： Min Wei
发明人： Min Wei
IPC分类号： A61M5/315 , A61M5/31
CPC分类号： A61M5/31505 , A61M5/3129 , A61M5/3137 , A61M5/3146 , A61M5/31515 , A61M5/31586 , A61M2005/3109 , A61M2005/3123 , A61M2005/3139 , A61M2005/31508
摘要： A pre-filled syringe for sterile medication fluid injection includes a syringe barrel with rotationally symmetric cylindrical bore, having a distal end and a proximal end; a syringe piston with rotationally symmetric external shape; a backstop mounted at the proximal end of the syringe barrel with an opening that is rotationally asymmetric about the axis through the syringe barrel; a push rod to move the syringe piston inside the syringe barrel, wherein at least one portion of the push rod is rotationally asymmetric about the axis through the syringe barrel, and upon rotation, the rotationally asymmetric portion of the push rod is aligned with the rotationally asymmetric opening of the backstop; and a seal component to cover the distal end of the syringe barrel.

10. 发明授权

US10049189B2 Method for developing parenteral therapeutic product with drug delivery device through clinical trial 有权
公开(公告)号：US10049189B2
公开(公告)日：2018-08-14
申请号：US14859296
申请日：2015-09-19
申请人： Min Wei
发明人： Min Wei
IPC分类号： G06Q10/00 , G06Q50/00 , G06F19/00 , G16H10/20 , A61M5/142 , A61M5/145 , A61M5/20 , A61M5/24 , A61M5/315
摘要： The method set out herein involves conducting clinical trial to develop parenteral therapeutic product with drug delivery device. The method comprises conducting a dose-finding clinical study using a variable dose drug delivery device to evaluate multiple clinical doses, wherein the variable dose drug delivery device is automatic, portable and for user self-administration. During the dose-finding clinical study, both the performance of the drug and the performance of the variable dose drug delivery device are evaluated.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式